Navigating PSMF Requirements: Format, Structure, and Compliance Guide
In the pharmaceutical sector, maintaining rigorous safety standards is both a patient-care priority and a strict regulatory obligation. Under the updated guidelines from the National Coordination Centre - Pharmacovigilance Programme of India (NCC-PvPI) and the CDSCO, Marketing Authorization Holders (MAHs) must maintain a robust and compliant Pharmacovigilance System Master File (PSMF).
This comprehensive guide breaks down the mandatory format, structural components, and reporting timelines required to keep your organization fully audit-ready.
Key Takeaway
Every Marketing Authorization Holder (MAH) should maintain a continuously updated Pharmacovigilance System Master File (PSMF) that accurately reflects the current status of its pharmacovigilance system and complies with CDSCO and NCC-PvPI requirements.
What is a PSMF?
The PSMF is a dynamic, stand-alone document that provides a detailed description of the pharmacovigilance system used by a Marketing Authorization Holder (MAH) for its marketed products.
Crucially, the PSMF is not part of the Marketing Authorization dossier itself. It is maintained independently and must mirror the live, real-time status of your pharmacovigilance infrastructure.
1. Core Structure and Content Requirements
As per Chapter 1 of the official Indian Pharmacovigilance Guidance Document, a compliant PSMF must contain the following five core sections.
A. PV Personnel & Responsibilities
The Pharmacovigilance Officer-in-Charge (PVOIC): Every MAH must designate a qualified PVOIC who resides in India.
The designated officer must be a medical or pharmacy professional trained in adverse event analysis.
If the PVOIC is a pharmacist, a medically qualified back-up must be available for causality assessments.
- Complete contact information.
- Detailed CV mapping regulatory authority and responsibilities.
- Information regarding the designated Deputy PVOIC.
B. Organizational Structure
The PSMF should clearly define the organizational hierarchy responsible for pharmacovigilance activities.
- Internal organogram showing the PV hierarchy and authorized signatories.
- Documentation for outsourced activities handled through Contract Research Organizations (CROs).
- Details of delegated tasks, commercial arrangements, and validated IT hosting infrastructure.
C. Sources of Safety Data
The PSMF must clearly document how safety information is systematically collected, monitored, and maintained from every available reporting channel.
A robust pharmacovigilance system should demonstrate complete traceability from data collection through regulatory reporting.
- Spontaneous reporting by Healthcare Professionals (HCPs) and consumers.
- Medical inquiries, helpline data, and website "Contact Us" reports.
- Weekly literature monitoring across electronic databases such as PubMed.
- Digital and social media monitoring managed by the organization.
D. PV Processes & Systems
Every pharmacovigilance activity should be supported by documented procedures, validated systems, and a clearly defined operational workflow.
- Detailed process flow diagrams showing an Individual Case Safety Report (ICSR) from initial receipt, validation, medical evaluation, coding, and regulatory submission.
- Documentation covering computerized systems, validation status, change control procedures, backup policies, and database management.
- Evidence of data retention policies, including indefinite storage of electronic backups and secure archiving of hard-copy records for at least 10 years.
E. System Performance & Quality Management
Organizations should continuously monitor and improve the effectiveness of their pharmacovigilance system through measurable quality indicators.
- Documented monitoring of regulatory reporting timelines and compliance performance.
- Annual trend analysis using key performance metrics such as late versus on-time submissions.
- Maintenance of an active Corrective and Preventive Action (CAPA) tracker for findings arising from internal and external audits.
Why a Complete PSMF Matters
A well-structured Pharmacovigilance System Master File demonstrates that your organization maintains a compliant, transparent, and continuously monitored pharmacovigilance system. It also enables regulatory inspectors to verify processes, responsibilities, documentation, and quality controls efficiently during inspections and audits.
2. Reporting Compliance & Timelines
Compliance is not limited to maintaining documentation. Organizations must also ensure that adverse event reports are submitted within the timelines prescribed by the CDSCO and NCC-PvPI.
The latest guidance specifies clear calendar-day reporting timelines for forwarding adverse event information to the appropriate regulatory authorities.
Adverse Event Reporting Timelines
The updated guidance requires Marketing Authorization Holders (MAHs) to forward adverse event reports within defined calendar-day timelines.
| Adverse Event Type | Reporting Deadline | Regulatory Destination |
|---|---|---|
| Serious Adverse Events (SAEs) | Within 15 Calendar Days | CDSCO & NCC-PvPI |
| Non-Serious Adverse Events | Within 90 Calendar Days | CDSCO & NCC-PvPI |
Important Note: Events related to lack of therapeutic efficacy, manufacturing defects, or medication errors should also be documented and reported according to these timelines.
3. Example Checklist: A Ready-to-Use PSMF Template
Use this structural checklist curated by Glaers to ensure your Pharmacovigilance System Master File aligns with regulatory expectations.
Section 1: Cover & Administrative Data
- Title Page with Company Name.
- Master File Reference Number.
- Date of Compilation.
- Revision History.
- PVOIC & Deputy PVOIC signed CVs.
- Professional Certificates.
- Job Descriptions.
- 24/7 Contact Information.
Section 2: Organizational Layout
- Corporate Organogram.
- PV Reporting Structure.
- Safety Data Exchange Agreements.
- CRO Agreements.
Section 3: Operational Framework (SOP Index)
- ICSR Intake, Triage & Validation.
- MedDRA Coding.
- WHO-UMC Causality Assessment.
- PSUR / PBRER Schedule Management.
- Sugam Portal Uploading.
- Signal Detection.
- Risk Management Plan (RMP).
Section 4: IT & Infrastructure Log
- PV Software Inventory.
- Electronic Databases.
- User Acceptance Testing (UAT).
- Computer System Validation (CSV).
Section 5: Annexures
- Marketed Product List.
- Delegated Task Log.
- PV Audit Schedule.
- CAPA Tracker.
Maintaining Audit Readiness
Regulatory inspectors classify significant deficiencies within the PSMF as Critical or Major observations.
Failure to maintain an accurate, validated, and continuously updated master file may result in product recalls, inspection findings, warning letters, or suspension of marketing authorization.
Stay Inspection Ready
Embedding a structured PSMF into your Quality Management System helps maintain compliance, improves operational transparency, and prepares your organization for routine and unannounced regulatory inspections.
Architecting Your PV Framework with Glaers & Aizilus Technologies
Through Glaers, Aizilus Technologies delivers an end-to-end ecosystem combining pharmacovigilance consulting, compliance expertise, and cloud-native safety software.
1. Affordable GxP & Pharmacovigilance Consulting
- SOP Design & Gap Analysis.
- PSMF Development & Inspection Readiness.
- Safety Signal Monitoring.
2. Cloud-Native Safety Software
- GAMP 5 Validated Platform.
- 21 CFR Part 11 Compliance.
- Intelligent Workflow Automation.
- Secure Multi-user Cloud Platform.
Action Plan for Life Sciences Executives
01
Review Existing PSMF
Verify that your current documentation reflects your live PV system.
02
Modernize Your Safety Database
Replace fragmented documentation with a centralized digital system.
03
Prepare for Inspection
Train personnel and maintain complete documentation for every pharmacovigilance activity.
Secure Your Regulatory Standing
A structured, validated, and continuously maintained PSMF is no longer optional. It is a fundamental requirement for regulatory compliance and successful pharmacovigilance operations in India.
Ready to Strengthen Your Pharmacovigilance System?
Discover how Glaers can help your organization build, maintain, and optimize a fully compliant Pharmacovigilance System Master File while supporting end-to-end regulatory reporting.